Skip to main content
. 2023 Feb 1;3(2):e0001467. doi: 10.1371/journal.pgph.0001467

Fig 2. Government recognition as a priority (A) and availability of an advocacy group (B) for AKI, CKD, and kidney failure treatment and prevention.

Fig 2